Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Diclofenac (Zorvolex) in Osteoarthritis
NCT01510912Phase 3Completed
- Sponsor
- Iroko Pharmaceuticals, LLC
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac in osteoarthritis (OA), sponsored by Iroko Pharmaceuticals, LLC. Started Jan 2012; status: completed.
02
Drugs
diclofenac
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01510912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01510912.